scholarly article | Q13442814 |
P356 | DOI | 10.1158/0008-5472.CAN-06-0916 |
P698 | PubMed publication ID | 17108111 |
P50 | author | Varda Rotter | Q16131089 |
Ran Brosh | Q38327822 | ||
Michael Milyavsky | Q73482970 | ||
Yosef Buganim | Q88416666 | ||
Igor Shats | Q98280936 | ||
Naomi Goldfinger | Q114537350 | ||
Yoach Rais | Q114537361 | ||
Perry Stambolsky | Q114537362 | ||
P2093 | author name string | Xiaohu Tang | |
Ido Nachmany | |||
Eyal Kalo | |||
Hila Besserglick | |||
Marina Kalis | |||
P2860 | cites work | Transactivation of the EGR1 gene contributes to mutant p53 gain of function | Q38334166 |
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10750-10759 | |
P577 | publication date | 2006-11-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction | |
P478 | volume | 66 |
Q41972847 | Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination |
Q33762700 | Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition |
Q34009832 | Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3. |
Q42819037 | Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells |
Q33890980 | Dynamic expression patterns of ATF3 and p53 in the hippocampus of a pentylenetetrazole-induced kindling model |
Q28077156 | Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness |
Q91817209 | Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis |
Q38947220 | Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4. |
Q24681272 | Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II |
Q33687048 | Mutant p53 gain-of-function in cancer |
Q38197826 | Mutant p53 in cancer: new functions and therapeutic opportunities |
Q36293880 | Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). |
Q38846785 | Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation |
Q28570662 | Subcellular localization of Daxx determines its opposing functions in ischemic cell death |
Q37691694 | The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins |
Q38198487 | The paradigm of mutant p53-expressing cancer stem cells and drug resistance |
Q36777349 | Transcription regulation by mutant p53. |
Q39005896 | Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. |
Q37582777 | When mutants gain new powers: news from the mutant p53 field. |
Q45888635 | p53: balancing tumour suppression and implications for the clinic |
Search more.